Page last updated: 2024-10-30

metformin and Lymphohistiocytosis, Hemophagocytic

metformin has been researched along with Lymphohistiocytosis, Hemophagocytic in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Lymphohistiocytosis, Hemophagocytic: A group of related disorders characterized by LYMPHOCYTOSIS; HISTIOCYTOSIS; and hemophagocytosis. The two major forms are familial and reactive.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramírez-Bellver, JL1
Lopez, J1
Macias, E1
Fuertes, L1
Andres, I1
Alegria, V1
Gimeno, I1
Perez, A1
Perez, Y1
Requena, L1

Other Studies

1 other study available for metformin and Lymphohistiocytosis, Hemophagocytic

ArticleYear
Metformin-Induced Generalized Fixed Drug Eruption With Cutaneous Hemophagocytosis.
    The American Journal of dermatopathology, 2017, Volume: 39, Issue:6

    Topics: Aged, 80 and over; Biopsy; Diabetes Mellitus, Type 2; Drug Eruptions; Drug Substitution; Histiocytes

2017
chemdatabank.com